We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$223M
AUM Growth
+$7.56M
Cap. Flow
-$5.07M
Cap. Flow %
-2.27%
Top 10 Hldgs %
34.01%
Holding
113
New
10
Increased
50
Reduced
24
Closed
15

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$1.01M
2
KO icon
Coca-Cola
KO
+$717K
3
MRK icon
Merck
MRK
+$682K
4
IBM icon
IBM
IBM
+$675K
5
ESRX
Express Scripts Holding Company
ESRX
+$620K

Top Sells

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$2.2M
2
CVX icon
Chevron
CVX
+$2.11M
3
QCOM icon
Qualcomm
QCOM
+$2.03M
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$1.65M
5
EMC
EMC CORPORATION
EMC
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 23.26%
2 Technology 18.79%
3 Industrials 15.76%
4 Consumer Staples 9.71%
5 Energy 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$436B
$2.55M 1.14%
93,622
-3,250
-3% -$89.7K
EMC
27
DELISTED
EMC CORPORATION
EMC
$2.44M 1.09%
95,153
-47,014
-33% -$1.22M
TGT icon
28
Target
TGT
$63.4B
$2.41M 1.08%
33,182
-1,028
-3% -$76.7K
MRK icon
29
Merck
MRK
$307B
$2.36M 1.06%
46,864
+13,519
+41% +$682K
PRGO icon
30
Perrigo
PRGO
$1.47B
$2.31M 1.03%
15,965
+1,425
+10% +$219K
IPGP icon
31
IPG Photonics
IPGP
$4.16B
$2.2M 0.98%
24,670
+545
+2% +$46.7K
BMY icon
32
Bristol-Myers Squibb
BMY
$123B
$2.04M 0.91%
29,578
+4,500
+18% +$297K
CVX icon
33
Chevron
CVX
$378B
$1.99M 0.89%
22,100
-23,368
-51% -$2.11M
XYL icon
34
Xylem
XYL
$28.7B
$1.98M 0.88%
54,155
+1,945
+4% +$70.3K
SLB icon
35
SLB Ltd
SLB
$69.4B
$1.89M 0.84%
27,067
-13,220
-33% -$990K
UL icon
36
Unilever
UL
$133B
$1.87M 0.84%
38,627
+12,351
+47% +$603K
IRWD icon
37
Ironwood Pharmaceuticals
IRWD
$634M
$1.81M 0.81%
186,676
HON icon
38
Honeywell
HON
$71.7B
$1.77M 0.79%
19,010
ABBV icon
39
AbbVie
ABBV
$448B
$1.76M 0.79%
29,735
+2,510
+9% +$145K
KO icon
40
Coca-Cola
KO
$353B
$1.71M 0.76%
39,715
+16,900
+74% +$717K
HP icon
41
Helmerich & Payne
HP
$3.37B
$1.7M 0.76%
31,806
-18,349
-37% -$1.01M
CB icon
42
Chubb
CB
$137B
$1.66M 0.74%
14,162
+8,884
+168% +$1.01M
IBM icon
43
IBM
IBM
$200B
$1.63M 0.73%
12,366
+5,021
+68% +$675K
UNP icon
44
Union Pacific
UNP
$176B
$1.49M 0.67%
19,034
JCI icon
45
Johnson Controls International
JCI
$85B
$1.47M 0.66%
35,622
-21,716
-38% -$982K
SPTM icon
46
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.47M 0.66%
57,918
-12,000
-17% -$305K
DD
47
DELISTED
Du Pont De Nemours E I
DD
$1.32M 0.59%
19,879
+190
+1% +$12.1K
DYAX
48
DELISTED
DYAX CORPORATION
DYAX
$1.28M 0.57%
34,100
VFC icon
49
VF Corp
VFC
$6.62B
$1.28M 0.57%
21,771
MON
50
DELISTED
Monsanto Co
MON
$1.27M 0.57%
12,932
-7,105
-35% -$667K

Similar funds

Brian C. Broderick's Q4 2015 Portfolio in Review

As of Q4 2015, Brian C. Broderick held 113 positions worth $223M, up 3.5% from $216M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brian C. Broderick's Q4 2015 filing shows 10 new, 50 increased, 24 reduced and 15 closed positions. Its largest new stake was Express Scripts Holding Company: 7,233 shares worth $632K. The largest sale was Emerson Electric, an estimated $2.2M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick's largest Q4 2015 buy was Express Scripts Holding Company: 7,233 shares worth $632K.
  • Brian C. Broderick added most to Chubb in Q4 2015, an estimated $1.01M increase.
  • Brian C. Broderick's biggest Q4 2015 reduction was Emerson Electric, cutting an estimated $2.2M.
  • Brian C. Broderick fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $1.65M.
  • Brian C. Broderick's ten largest holdings make up 34% of its $223M portfolio in Q4 2015.
  • Brian C. Broderick opened 10 new positions and closed 15 in Q4 2015.
  • Brian C. Broderick's portfolio value rose 3.5% quarter-over-quarter to $223M.

Based on Brian C. Broderick's 13F filing for Q4 2015, filed 12 Feb 2016.